Toward organometallic antischistosomal drug candidates
Abstract
In the recent years, there has been a growing interest in the use of novel approaches for the treatment of parasitic diseases such as schistosomiasis. Among the different approaches used, organometallic compounds were found to offer unique opportunities in the design of antiparasitic drug candidates. A ferrocenyl derivative, namely ferroquine, has even entered clinical trials as a novel antimalarial. In this short review, we report on the studies describing the use of organometallic compounds against schistosomiasis.
Journal details
Journal Future Medicinal Chemistry
Volume 7
Issue number 6
Pages 821-830
Available online
Publication date
Full text links
Publisher website (DOI) 10.4155/fmc.15.22
Europe PubMed Central 25996072
Pubmed 25996072
Keywords
Type of publication